Collaborations and research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of CAL101 - a humanized monoclonal antibody targeting S100A4 to inhibit proinflammatory and profibrotic signaling
Borchert, S. V., Hallén, J., Hussain, R. I., Holyer, I., Troelsen, J. T. & Klingelhöfer, J., Nov 2025, In: Journal of Pharmacology and Experimental Therapeutics. 392, 11, 12 p., 103722.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile6 Downloads (Pure) -
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer
Pfeiffer, A., Di Leo, L., Bechmann, M. B., Nawabi, M., Ambjørner, S., Ardeshir-Larijani, D., Colstrup, L. T., Borchert, S. V., Saaby, L., Brodin, B., Gajhede, M., Lund, X. L., Čečková, M., Brünner, N. & Stenvang, J., 17 Apr 2025, In: International Journal of Molecular Sciences. 26, 8, 23 p., 3790.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus)30 Downloads (Pure) -
Mechanistic and Pharmacokinetic Characterization of CAL101, a Novel Anti-S100A4 Antibody for Fibrotic Indications
Borchert, S. V., 2025, Roskilde: Roskilde Universitet. 137 p.Research output: Book/Report › Ph.D. thesis
-
Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis–Specific Transcriptional Signatures in Human Skin
Trinh-Minh, T., Györfi, A. H., Tomcik, M., Tran-Manh, C., Zhou, X., Dickel, N., Tümerdem, B. S., Kreuter, A., Burmann, S. N., Borchert, S. V., Hussain, R. I., Hallén, J., Klingelhöfer, J., Kunz, M. & Distler, J. H. W., May 2024, In: Arthritis and Rheumatology. 76, 5, p. 783-795 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile19 Link opens in a new tab Citations (Scopus)134 Downloads (Pure)